Evidence map›Paper›PMID 40196059›Full record

ArticleCureus2025

Dedifferentiated Liposarcoma of the Spermatic Cord: A Case Report and Review of the Literature.

Yuki Matsui, Wahei Yanagida, Hirotaka Kishi, Jun Morita, Takashi Fukagai

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuki MatsuiDepartment of Urology, Showa University School of Medicine, Tokyo, JPN.
Wahei YanagidaDepartment of Urology, Showa University School of Medicine, Tokyo, JPN.
Hirotaka KishiDepartment of Urology, Showa University School of Medicine, Tokyo, JPN.
Jun MoritaDepartment of Urology, Showa University School of Medicine, Tokyo, JPN.
Takashi FukagaiDepartment of Urology, Showa University School of Medicine, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spermatic cord liposarcomas are rare malignant neoplasms with no established level-one evidence-based treatment guidelines. Well-differentiated liposarcomas (WDL) lack metastatic potential but can transform into dedifferentiated liposarcomas (DDL), which are more aggressive. Due to the rarity of these tumors, treatment recommendations are primarily based on retrospective studies and extrapolated data from extremity sarcomas. We report a case of a DDL managed with radical orchiectomy and en bloc resection, along with a literature review on spermatic cord liposarcomas, focusing on imaging, histopathology, and treatment strategies. Imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), aid in tumor characterization, while histopathological examination remains the gold standard for diagnosis. Surgical management prioritizes R0 resection, as incomplete excision is associated with high recurrence rates. The role of adjuvant therapy remains controversial, with limited evidence supporting its routine use. In our case, complete resection with negative margins was achieved, and clinical follow-up was chosen over adjuvant treatment. Given the aggressive nature of high-grade liposarcomas and their tendency for local recurrence, wide surgical excision with negative margins remains the primary treatment. The role of adjuvant chemotherapy and radiotherapy is unclear and may be considered in high-risk cases. Further research is needed to establish standardized treatment protocols.

Indexed as

chemotherapydedifferentiated liposarcomagenitourinary oncologyhistopathologyprognosisradiotherapyretroperitoneal sarcomasoft tissue sarcomaspermatic cordsurgical oncology

Identifiers

PMID40196059
PMCPMC11975456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.